Open Access<p>Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]</p>
Author(s) -
Yazeed Sawalha,
David A. Bond,
Lapo Alinari
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s278185
Subject(s) - medicine , mantle cell lymphoma , refractory (planetary science) , oncology , cancer research , lymphoma , bioinformatics , biology , astrobiology